Karen L. Bergman
Investor Relations Contact chez BOLT BIOTHERAPEUTICS, INC.
Profil
Karen L.
Bergman is the founder of BCC Partners LLC.
She is currently the Vice President-Communications & Investor Relations at Bolt Biotherapeutics, Inc. Prior to this, she held the same position at ALZA Corp.
and was also the Vice President-Investor Relations & Communications at FibroGen, Inc. Ms. Bergman completed her undergraduate degree at Yale University.
Postes actifs de Karen L. Bergman
| Sociétés | Poste | Début |
|---|---|---|
| BOLT BIOTHERAPEUTICS, INC. | Investor Relations Contact | - |
Anciens postes connus de Karen L. Bergman
| Sociétés | Poste | Fin |
|---|---|---|
| BCC Partners LLC | Founder | - |
| ALZA CORPORATION | Investor Relations Contact | - |
| FIBROGEN, INC. | Investor Relations Contact | - |
Formation de Karen L. Bergman
| Yale University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| FIBROGEN, INC. | Health Technology |
| BOLT BIOTHERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
| BCC Partners LLC |
